Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Mirum Pharmaceuticals, Inc. (MIRM), most recent 12 months reported: revenue $618.07M, net loss $860.21M, free cash flow -$228.74M. Latest balance sheet on file: liquid cash $438.29M, total debt $750.08M, net cash -$311.79M. From SEC filings. More on Mirum Pharmaceuticals, Inc.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: ULTRAGENYX PHARMACEUTICAL INC. · BridgeBio Pharma, Inc. · NURIX THERAPEUTICS, INC. · ARROWHEAD PHARMACEUTICALS, INC. · TRAVERE THERAPEUTICS, INC. · OPKO Health, Inc. · HutchMED (China) LIMITED · Vireo Growth Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.